Bearish On Large Cap Pharma Stocks: Surjit Pal

  • 4:17
  • Published On: November 04, 2016
Cinema View
Embed
Surjit Pal, pharma sector analyst at Prabhudas Lilladher, said that in the near to medium term, large cap pharma shares are not likely to achieve the kind of growth they had clogged in the last 5-6 years.

Related Videos

Sensex Opens Higher, All Eyes On GST
June 27, 2017 2:13
Regulatory Environment Unfavourable For Pharma Companies: Surjit Pal
May 23, 2017 9:10
Still Cautious On Pharma Stocks: Hemen Kapadia
May 03, 2017 28:05
Q4 Review Of NBFCs
April 26, 2017 12:31
Positive On D-Mart For Long Term: Amnish Aggarwal
March 22, 2017 11:32
Ace Women Investors Devina Mehra & Amisha Vora Share Investment Mantras
March 08, 2017 22:31
Nifty Likely To Remain Firm, May Rally Further: R Sreesankar
March 02, 2017 15:07
Accumulate Bank of Baroda: R Sreesankar
February 13, 2017 10:36
Q3 Of FMCG Companies To Be 'Significantly' Muted: Amnish Aggarwal
December 29, 2016 10:54
Selectively Buy NBFCs: Prabhudas Lilladher
December 27, 2016 10:39
Dream Run In Pharma Shares Over: Jay Thakkar
December 23, 2016 10:29
Markets Face Tough Challenges: Ajay Bodke
December 23, 2016 11:34
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination